1 |
Morales L, Oliveros JC, Enjuanes L, Sola I. Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology. mBio 2022;:e0313521. [PMID: 35229638 DOI: 10.1128/mbio.03135-21] [Reference Citation Analysis]
|
2 |
Tam RY, van Dorst JM, McKay I, Coffey M, Ooi CY. Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions. J Clin Med 2022;11:649. [PMID: 35160099 DOI: 10.3390/jcm11030649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
3 |
Cao T, Hong J, Qi F, Zheng B, Chen G, Yu B, Ye F, Tang M. A Hyperglycemic Microenvironment Inhibits Tendon-to-Bone Healing through the let-7b-5p/CFTR Pathway. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/8268067] [Reference Citation Analysis]
|
4 |
Johansson K, Woodruff PG, Ansel KM. Regulation of airway immunity by epithelial miRNAs. Immunol Rev 2021. [PMID: 34549450 DOI: 10.1111/imr.13028] [Reference Citation Analysis]
|
5 |
Ruiz-manriquez LM, Ledesma Pacheco SJ, Medina-gomez D, Uriostegui-pena AG, Estrada-meza C, Bandyopadhyay A, Pathak S, Banerjee A, Chakraborty S, Srivastava A, Paul S. A Brief Review on the Regulatory Roles of MicroRNAs in Cystic Diseases and Their Use as Potential Biomarkers. Genes 2022;13:191. [DOI: 10.3390/genes13020191] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Ensinck MM, Carlon MS. One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies. Cells 2022;11:1868. [PMID: 35740997 DOI: 10.3390/cells11121868] [Reference Citation Analysis]
|